ARCA BIOPHARMA INC (ABIO)
US00211Y5069 - Common Stock
ABIO Stock Earnings: ARCA biopharma Reported Results for Q1 2024
ARCA biopharma just reported results for the first quarter of 2024.
ABIO Stock Earnings: ARCA biopharma Reported Results for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ARCA biopharma (NASDAQ:ABIO) just reported results for the first quarter of 202...
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, CHX, KTRA, ABIO
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Why Is ARCA Biopharma (ABIO) Stock Up 85% Today?
With ARCA Biopharma announcing a potentially lucrative merger with Oruka Therapeutics, ABIO stock skyrocketed on the news.
Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka
/PRNewswire/ -- Ademi LLP is investigating ARCA (NASDAQ: ABIO) for possible breaches of fiduciary duty and other violations of law in its transaction with...
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
Merger to create a company focused on advancing Oruka’s portfolio of novel biologics that aim to redefine the standard of care for patients with chronic...
ARCA biopharma Announces 2023 Financial Results
ARCA biopharma Announces 2023 Financial Results...
ARCA biopharma Announces Third Quarter 2023 Financial Results
ARCA biopharma Announces Third Quarter 2023 Financial Results...
ARCA biopharma Announces Second Quarter 2023 Financial Results
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options ...
ARCA biopharma Announces First Quarter 2023 Financial Results
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options...
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options...
James Flynn Joins ARCA biopharma Board of Directors
WESTMINSTER, Colo., Dec. 19, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that James Flynn has joined its Board of...
ARCA biopharma Announces Third Quarter 2022 Financial Results
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options...
ARCA biopharma Announces Second Quarter 2022 Financial Results
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options ...
Jacob Ma-Weaver Joins ARCA biopharma Board of Directors
WESTMINSTER, Colo., June 21, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that Jacob Ma-Weaver has joined its Board of...
ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review
WESTMINSTER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that it has retained Ladenburg Thalmann &...
ARCA biopharma Announces First Quarter 2022 Financial Results
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options ...
ARCA biopharma Establishes Special Committee of the Board of Directors
WESTMINSTER, Colo., April 18, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
If you're looking for the biggest pre-market stock movers for Monday, we've got you covered with a list of gainers and losers for today.